Towards mRNA with superior translational activity: synthesis and properties of ARCA tetraphosphates with single phosphorothioate modifications
- 10 March 2010
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 34 (5), 993-1007
- https://doi.org/10.1039/b9nj00644c
Abstract
We describe the chemical synthesis and preliminary biophysical and biochemical characterization of a series of mRNA 5′-end (cap) analogs designed as reagents for obtaining mRNA molecules with augmented translation efficiency and stability in vivo and as useful tools to study mRNA metabolism. The analogs share three structural features: (i) the 5′,5′-bridge is elongated to a tetraphosphate to increase their affinity to translation initiation factor eIF4E; (ii) a single phosphorothioate modification at either the α, β, γ or δ-position of the tetraphosphate has been made to decrease their susceptibility to enzymatic degradation and/or to modulate their interaction with specific proteins; and (iii) a 2′-O-methyl group has been added to the ribose of 7-methylguanosine (a characteristic of Anti-Reverse Cap Analogs (ARCAs), which are incorporated into mRNA during in vitro transcription exclusively in the correct orientation). The dinucleotides bearing the modified tetraphosphate bridge were synthesized by ZnCl2 -mediated coupling between two mononucleotide subunits with isolated yields of 30–65%. The preliminary biochemical results show that mRNAs capped with new analogs are 2.5–4.5 times more efficiently translated in a cell-free system than m7GpppG-capped mRNAs, which makes them promising candidates for RNA-based therapeutic applications such as gene therapy and anticancer vaccines.Keywords
This publication has 53 references indexed in Scilit:
- Synthesis of boranoate, selenoate, and thioate analogs of AZTp4A and Ap4ATetrahedron, 2009
- Dinucleoside polyphosphates: strong endogenous agonists of the purinergic systemBritish Journal of Pharmacology, 2009
- eIF4E: New Family Members, New Binding Partners, New RolesPublished by Elsevier BV ,2009
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological StabilityMolecular Therapy, 2008
- DcpS as a Therapeutic Target for Spinal Muscular AtrophyACS Chemical Biology, 2008
- Synthesis and characterization of mRNA cap analogs containing phosphorothioate substitutions that bind tightly to eIF4E and are resistant to the decapping pyrophosphatase DcpSRNA, 2008
- DcpS scavenger decapping enzyme can modulate pre-mRNA splicingRNA, 2008
- Synthesis and application of 2′-fluoro-substituted cap analogsBioorganic & Medicinal Chemistry Letters, 2007
- Phosphorothioate cap analogs stabilize mRNA and increase translational efficiency in mammalian cellsRNA, 2007
- mRNA transfection of dendritic cells: Synergistic effect of ARCA mRNA capping with Poly(A) chains in cis and in trans for a high protein expression levelBiochemical and Biophysical Research Communications, 2006